The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data<sup/>.

TitleThe eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.
Publication TypeJournal Article
Year of Publication2018
AuthorsRutherford SC, Stewart EN, Chen Z, Chadburn A, Wehrli NE, Van Besien K, Martin P, Furman RR, Leonard JP, Cerchietti L
JournalLeuk Lymphoma
Volume59
Issue1
Pagination256-258
Date Published2018 01
ISSN1029-2403
KeywordsAntiviral Agents, Eukaryotic Initiation Factor-4E, Humans, Lymphoma, Remission Induction, Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses, Retrospective Studies, Ribavirin
DOI10.1080/10428194.2017.1323270
Alternate JournalLeuk Lymphoma
PubMed ID28573908
Related Faculty: 
Amy Chadburn, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700